Spliceosome structures have been investigated extensively in the past decade, but most of the studies have been restricted to ...

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nature Materials , 2025; DOI: 10.1038/s41563-024-02114-5 Cite This Page : ...

The Montana House on Wednesday voted down a bill that would have banned mRNA vaccines statewide, including the Covid-19 vaccine. After passing out of committee on a party line vote last week ...

Vaccines using messenger RNA, or mRNA, technology became widespread during the pandemic. With limited long-term studies available, the Trump administration is revisiting these vaccines. In response to ...

ICIT builds on the promise of circular mRNAs, a new generation of mRNA treatments known for their stability and reduced inflammatory effects compared to traditional linear mRNAs. Unlike linear ...

Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, Ghent 9000, Belgium ...

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market open. Here’s what to expect. Moderna beat analysts’ revenue expectations by 48.8% last ...

In a new study published recently in the journal Cell Reports, Yale researchers reveal that mRNA, or messenger RNA, plays a significant role in cell migration, a duty that also dramatically expands ...